Free Trial

MDxHealth (MDXH) Competitors

MDxHealth logo
$1.99 +0.03 (+1.53%)
As of 01/21/2025 04:00 PM Eastern

MDXH vs. OPGN, BGLC, ACON, FRES, NTRA, LH, DGX, EXAS, RDNT, and GH

Should you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include OpGen (OPGN), BioNexus Gene Lab (BGLC), Aclarion (ACON), Fresh2 Group (FRES), Natera (NTRA), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Exact Sciences (EXAS), RadNet (RDNT), and Guardant Health (GH). These companies are all part of the "medical laboratories" industry.

MDxHealth vs.

MDxHealth (NASDAQ:MDXH) and OpGen (NASDAQ:OPGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

MDxHealth has a net margin of -49.52% compared to OpGen's net margin of -1,140.36%. OpGen's return on equity of 0.00% beat MDxHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
MDxHealth-49.52% -1,077.84% -28.82%
OpGen -1,140.36%N/A -287.58%

OpGen received 286 more outperform votes than MDxHealth when rated by MarketBeat users. However, 55.56% of users gave MDxHealth an outperform vote while only 53.18% of users gave OpGen an outperform vote.

CompanyUnderperformOutperform
MDxHealthOutperform Votes
15
55.56%
Underperform Votes
12
44.44%
OpGenOutperform Votes
301
53.18%
Underperform Votes
265
46.82%

MDxHealth has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, OpGen has a beta of -0.49, indicating that its share price is 149% less volatile than the S&P 500.

MDxHealth currently has a consensus target price of $7.00, indicating a potential upside of 251.76%. Given MDxHealth's stronger consensus rating and higher possible upside, equities research analysts plainly believe MDxHealth is more favorable than OpGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MDxHealth
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
OpGen
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

OpGen has lower revenue, but higher earnings than MDxHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MDxHealth$70.19MN/A-$43.10M-$1.52-1.31
OpGen$2.67M3.63-$32.67MN/AN/A

In the previous week, MDxHealth and MDxHealth both had 1 articles in the media. MDxHealth's average media sentiment score of 0.00 equaled OpGen'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MDxHealth
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OpGen
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

2.7% of OpGen shares are held by institutional investors. 1.7% of MDxHealth shares are held by company insiders. Comparatively, 43.8% of OpGen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

MDxHealth beats OpGen on 8 of the 13 factors compared between the two stocks.

Get MDxHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDXH vs. The Competition

MetricMDxHealthMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market CapN/A$3.05B$5.38B$9.13B
Dividend YieldN/A16.58%5.37%4.00%
P/E Ratio-1.3115.0786.9417.29
Price / SalesN/A204.351,267.38137.12
Price / CashN/A393.5036.6032.88
Price / Book0.435.244.974.69
Net Income-$43.10M-$33.85M$117.89M$224.57M
7 Day Performance-0.50%4.49%1.72%1.69%
1 Month Performance-11.95%1.06%3.67%5.34%
1 Year Performance-48.45%17.87%26.11%21.47%

MDxHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDXH
MDxHealth
1.9283 of 5 stars
$1.99
+1.5%
$7.00
+251.8%
-46.4%$0.00$70.19M-1.31300
OPGN
OpGen
N/A$0.80
+1.3%
N/A-54.3%$6.69M$2.67M0.00100Analyst Forecast
BGLC
BioNexus Gene Lab
0.4991 of 5 stars
$0.34
+2.4%
N/A-27.5%$6.02M$9.26M0.0030Positive News
Gap Up
ACON
Aclarion
1.6719 of 5 stars
$0.11
-6.9%
$1.30
+1,090.5%
-98.5%$1.35M$49,289.000.007
FRES
Fresh2 Group
N/A$0.85
flat
N/AN/A$763,000.00$16.98M0.0075
NTRA
Natera
2.41 of 5 stars
$169.30
-3.3%
$158.00
-6.7%
+151.3%$22.35B$1.53B-96.193,293
LH
Laboratory Co. of America
4.853 of 5 stars
$234.16
+0.9%
$260.54
+11.3%
+8.1%$19.58B$12.71B45.2975,500Positive News
DGX
Quest Diagnostics
4.975 of 5 stars
$153.89
+1.4%
$172.15
+11.9%
+15.1%$17.18B$9.54B20.6848,000Short Interest ↑
Positive News
EXAS
Exact Sciences
4.8179 of 5 stars
$58.51
+3.6%
$72.94
+24.7%
-17.6%$10.83B$2.69B-50.016,600News Coverage
RDNT
RadNet
4.0813 of 5 stars
$66.59
-3.2%
$84.75
+27.3%
+59.3%$4.93B$1.77B-951.158,970High Trading Volume
GH
Guardant Health
3.4313 of 5 stars
$38.10
+3.8%
$40.60
+6.6%
+94.4%$4.71B$692.26M-8.991,779News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:MDXH) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners